| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 17 | 19 | 21 | 32 | 25 | 30 | 38 | 32 | 37 | 39 | 37 | 50 | 48 | 51 | 54 | 56 | 61 | 75 | 93 | 105 | 117 | 137 | 142 | 138 | 134 | 174 | 163 | 1,314 | 161 | 197 | 260 | 285 | 322 | 348 | 368 | 395 | 325 | 299 | 296 | 270 | 308 | 324 | 307 | 359 |
| Expenses | 22 | 23 | 28 | 38 | 35 | 36 | 41 | 38 | 41 | 44 | 39 | 45 | 52 | 56 | 60 | 65 | 75 | 89 | 105 | 116 | 132 | 137 | 144 | 141 | 141 | 178 | 169 | 156 | 194 | 222 | 269 | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 468 | 307 | 311 | 292 | 324 | 356 |
| EBITDA | -6 | -4 | -7 | -5 | -10 | -6 | -3 | -5 | -4 | -5 | -2 | 5 | -4 | -5 | -7 | -8 | -14 | -14 | -12 | -11 | -15 | 0 | -2 | -2 | -7 | -4 | -6 | 1,158 | -33 | -25 | -8 | -6 | -3 | 21 | 13 | 24 | 8 | 26 | -172 | -38 | -3 | 31 | -17 | 3 |
| Operating Profit % | -43 % | -27 % | -37 % | -18 % | -43 % | -23 % | -9 % | -18 % | -19 % | -14 % | -8 % | -3 % | -11 % | -13 % | -13 % | -19 % | -24 % | -19 % | -13 % | -12 % | -14 % | -0 % | -2 % | -2 % | -6 % | -3 % | -6 % | -9 % | -24 % | -16 % | -6 % | -4 % | -4 % | 3 % | 1 % | 1 % | -3 % | -1 % | -71 % | -9 % | -9 % | 2 % | -8 % | -3 % |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -8 | -6 | -9 | -8 | -13 | -8 | -5 | -8 | -7 | -7 | -4 | 3 | -5 | -7 | -9 | -11 | -16 | -16 | -14 | -12 | -16 | -1 | -3 | -4 | -9 | -6 | -8 | 1,157 | -34 | -26 | -11 | -9 | -6 | 19 | 11 | 21 | 5 | 25 | -174 | -39 | -5 | 30 | -19 | 1 |
| Tax | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | -5 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 1 | 1 | 133 | -8 | -1 | -8 | 18 | 42 | 19 | 23 | 24 | -17 | -16 | -19 | -1 | -22 | 4 | -3 | 1 |
| Net Profit | -6 | -6 | -9 | -8 | -12 | -9 | -5 | -8 | -7 | -7 | -4 | 2 | -5 | -7 | -9 | -11 | -16 | -10 | -14 | -12 | -15 | -1 | -4 | -4 | -9 | -6 | -9 | 1,024 | -26 | -25 | -3 | -26 | -48 | -0 | -12 | -3 | 22 | 41 | -155 | -38 | 18 | 27 | -15 | 0 |
| EPS in ₹ | -1.96 | -1.91 | -2.83 | -2.43 | -3.80 | -2.69 | -1.67 | -2.43 | -2.24 | -2.20 | -0.97 | -0.68 | -1.33 | -1.92 | -2.47 | -3.02 | -4.39 | -2.62 | -3.82 | -2.69 | -3.06 | -0.04 | -0.70 | -0.63 | -1.90 | -1.14 | -1.43 | 232.31 | -6.07 | -6.24 | -0.39 | -6.00 | -10.75 | 0.41 | -2.55 | -0.23 | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 | -3.99 | 0.35 |
Sastasundar Ventures
Sastasundar Ventures
273.00
+2.65
(0.98%)
Market Cap
868.43 Cr
PE Ratio
29.63
Volume
7,957.00
Day High - Low
273.95 - 267.90
52W High-Low
363.00 - 241.60
Key Fundamentals
Market Cap
868.43 Cr
EPS
-28.66
PE Ratio
29.63
PB Ratio
1.27
Book Value
214.24
EBITDA
3.80
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
-15.45
Debt to Equity
0.00
Actual
Company News
View All News
Health X Platform Limited receives SEBI compliance certificate from registrar MUFG Intime India for Q4 FY26, confirming proper dematerialisation processes and regulatory adherence.
Promoter Mr. Banwari Lal Mittal acquired 5,000 equity shares worth Rs. 13.76 lakh through market purchase, increasing his shareholding from 33.91% to 33.92%.
Banwari Lal Mittal and promoter group acquired 1,90,355 shares worth Rs. 14.03 lakh between November 2025 to March 2026, increasing collective holding from 74.24% to 74.84% in Health X Platform Limited.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,437.00 | #1 24,077.66 | 44.54 | #1 2,554.80 | 11.28 | #1 492 | -6.83 | 61.51 | |
1,036.20 | 10,662.16 | 65.81 | 699.70 | 23.06 | 144 | 22.38 | 71.86 | |
484.30 | 10,040.88 | 58.21 | 1,346.30 | 10.64 | 146 | 33.65 | 63.59 | |
387.50 | 6,167.66 | 46.03 | 702.20 | 20.80 | 91 | 47.37 | 52.10 | |
562.50 | 5,644.17 | 80.57 | 769.90 | 33.97 | 67 | 60.20 | 53.38 | |
612.05 | 1,985.41 | 25.20 | 742.70 | 16.70 | 78 | -21.13 | 53.78 | |
282.16 | 1,469.51 | 45.20 | 255.90 | 15.11 | 31 | 20.00 | 63.84 | |
1,388.05 | 1,191.32 | 19.22 | 111.60 | 28.72 | 48 | 65.93 | - | |
555.90 | 1,086.43 | #1 18.57 | 147.80 | #1 134.60 | 19 | #1 520.00 | 45.09 | |
273.00 | #10 868.43 | #4 29.63 | #3 1,170.80 | #10 -18.47 | #10 -134 | #2 101.06 | 48.51 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-18.47 %
Net Income Growth
-2,362.71 %
Cash Flow Change
-148.27 %
ROE
-2,718.64 %
ROCE
750.91 %
EBITDA Margin (Avg.)
-92.79 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 281 | 256 | 251 | 236 | 231 | 316 | 293 | 1,278 | 1,206 | 1,150 | 974 |
| Fixed Assets | 138 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 |
| Current Assets | 88 | 90 | 108 | 95 | 66 | 137 | 131 | 508 | 575 | 354 | 267 |
| Capital Work in Progress | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 |
| Investments | 4 | 1 | 8 | 28 | 36 | 56 | 43 | 666 | 513 | 676 | 575 |
| Other Assets | 137 | 129 | 119 | 89 | 77 | 146 | 139 | 518 | 585 | 363 | 287 |
| Total Equity & Liabilities | 281 | 256 | 251 | 236 | 231 | 316 | 293 | 1,278 | 1,206 | 1,150 | 974 |
| Current Liabilities | 22 | 31 | 49 | 27 | 22 | 66 | 60 | 68 | 110 | 79 | 105 |
| Non Current Liabilities | 4 | 7 | 7 | 5 | 8 | 3 | 3 | 116 | 102 | 72 | 5 |
| Total Equity | 255 | 218 | 195 | 203 | 200 | 246 | 229 | 1,094 | 994 | 1,000 | 865 |
| Reserve & Surplus | 223 | 186 | 158 | 144 | 106 | 173 | 163 | 790 | 717 | 726 | 638 |
| Share Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | -0 | -19 |
| Investing Activities | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Operating Activities | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Financing Activities | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 74.43 % | 74.43 % | 74.43 % | 73.72 % | 73.72 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.94 % | 74.11 % | 74.24 % | 74.24 % | 74.69 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.32 % | 0.49 % | 0.56 % | 0.61 % | 0.99 % | 1.71 % | 1.60 % | 1.88 % | 2.04 % | 2.25 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.09 % | 0.09 % | 0.09 % | 0.17 % | 0.17 % | 0.86 % | 0.96 % | 1.35 % | 1.98 % | 1.85 % | 2.06 % | 2.09 % | 2.07 % | 2.07 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 11.41 % | 13.05 % | 13.03 % | 13.80 % | 14.49 % | 14.70 % | 15.01 % | 15.24 % | 15.09 % | 15.17 % | 15.64 % | 16.52 % | 16.06 % | 15.05 % | 14.47 % | 14.09 % | 13.70 % | 13.35 % | 12.84 % | 12.72 % |
| Others | 14.16 % | 12.52 % | 12.55 % | 12.48 % | 11.79 % | 11.38 % | 10.98 % | 10.76 % | 10.90 % | 10.74 % | 9.95 % | 8.20 % | 8.51 % | 9.07 % | 8.63 % | 8.41 % | 8.52 % | 8.44 % | 8.81 % | 8.27 % |
| No of Share Holders | 11,797 | 13,034 | 13,090 | 14,276 | 15,174 | 15,247 | 15,554 | 15,166 | 15,088 | 14,752 | 14,633 | 14,053 | 14,544 | 14,493 | 15,360 | 14,093 | 13,693 | 13,452 | 13,012 | 12,287 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Sept 2016 |  Change Of Name | NA | 27 Sept 2016 | 0.00 | 0.00 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 307.85 | 306.45 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 335.25 | 319.50 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 282.35 | 275.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 269.90 | 265.45 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 284.40 | 292.65 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 271.55 | 307.40 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 298.55 | 289.55 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 301.15 | 299.70 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Apr 06, 2026
Apr 06, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Apr 01, 2026
Apr 01, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2026
Mar 28, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 27, 2026
Mar 27, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 23, 2026
Mar 23, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Mar 16, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 16, 2026
Mar 16, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Mar 05, 2026Disclosure under Regulation 30A of LODRFeb 27, 2026
Feb 27, 2026Disclosure Under Reg 30(9) Of SEBI (LODR) - Intimation By Sastasundar Healthbuddy Limited Material Subsidiary Regarding Outcome Of Its Board MeetingFeb 27, 2026
Feb 27, 2026Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board Of DirectorsFeb 27, 2026
Feb 27, 2026Disclosure Under Reg 30 (LODR) - Intimation By Sastasundar Healthbuddy Limited Material Subsidiary Regarding Outcome Of Its Board MeetingFeb 26, 2026
Feb 26, 2026Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board Of DirectorsFeb 26, 2026
Feb 26, 2026Disclosure Under Reg 30 Of SEBI (LODR) Reg - Execution Of Share Purchase Agreement By Sastasundar Healthbuddy Limited Material Subsidiary Of The CompanyFeb 25, 2026
Feb 25, 2026Announcement under Regulation 30 (LODR)-Change of Company NameFeb 20, 2026
Feb 20, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Feb 20, 2026
Feb 20, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Feb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 16, 2026
Feb 16, 2026Disclosure Under Reg 30 - Update On The Reduction Of Share Capital Of Step-Down Subsidiary Of The CompanyFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 13, 2026
Feb 13, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 13, 2026
Feb 13, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Results - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025Feb 06, 2026
Feb 06, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th February 2026Feb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Feb 02, 2026Board Meeting Intimation for Prior Intimation For Board Meeting To Be Held On 6Th February 2026Jan 29, 2026
Jan 29, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Jan 14, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2026
Jan 14, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 13, 2026
Jan 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th January 2026 - Intimation Under Reg 30 Of SEBI (LODR) Reg 2015
Jan 07, 2026
Jan 07, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 17, 2025
Dec 17, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 11, 2025
Dec 11, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2025
Dec 04, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 02, 2025
Dec 02, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 29, 2025
Nov 29, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 24, 2025
Nov 24, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 22, 2025
Nov 22, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 20, 2025
Nov 20, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 19, 2025
Nov 19, 2025Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Nov 18, 2025
Nov 18, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.02% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 45.56
ATR(14)
Less Volatile 9.96
STOCH(9,6)
Neutral 43.02
STOCH RSI(14)
Overbought 81.58
MACD(12,26)
Bullish 0.54
ADX(14)
Weak Trend 17.18
UO(9)
Bearish 36.33
ROC(12)
Uptrend And Accelerating 5.22
WillR(14)
Neutral -39.39
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
